allogeneic adipose-derived mesenchymal stem cell therapy (Biodan Yelah)

N/A

Report date: 2025/03/14 16:20:41

Base Information

Drug Nameallogeneic adipose-derived mesenchymal stem cell therapy (Biodan Yelah)

Drug Alias NameN/A

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Adipose stem cell therapyCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsEpidermolysis Bullosa

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritorySpain

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBiodan Yelah SL

China Registration ClassN/A

Develop Information

Active CompaniesBiodan Yelah SL

Inactive CompaniesN/A

Active IndicationsEpidermolysis Bullosa

Inactive IndicationsN/A

Other Information

ATC CodeN/A